Changeflow GovPing Healthcare FDA Survey Comment Form
Routine Consultation Added Consultation

FDA Survey Comment Form

Favicon for www.regulations.gov Regs.gov: Food and Drug Administration
Published June 2nd, 2026
Detected April 3rd, 2026
Email

Summary

The Food and Drug Administration (FDA) has opened a public comment period on a survey (Docket FDA-2026-N-2740-0001) via regulations.gov. The comment period remains open until June 2, 2026. This is a standard consultation seeking public input on an unspecified FDA survey topic.

What changed

FDA has published a comment form for a survey (FDA-2026-N-2740-0001) on regulations.gov. The consultation is open for public comments through June 2, 2026. Commenters may submit feedback as individuals, organizations, or anonymously, with support for file attachments up to 10MB.

Regulated entities and stakeholders who wish to provide input on FDA survey questions or methodology should submit comments by June 2, 2026. No specific compliance obligations or penalties are associated with this consultation. Parties should note that any personally identifiable information submitted may be publicly disclosed.

Source document (simplified)

Write a Comment

Commenter's Checklist
Public Comments on Federal Regulations

Comment *

5000

What is your comment about?

Attach Files

You can attach up to 20 files, but each file cannot exceed 10MB. Valid file types include: bmp, docx, gif, jpg, jpeg, pdf, png, pptx, rtf, sgml, tif, tiff, txt, wpd, xlsx, xml. Drop files here or Browse...

Email Address

Opt to receive email confirmation of submission and tracking number?
If you choose to identify as Anonymous, the option to receive an email confirmation will not be displayed. (We will never post the email address entered in the field above on Regulations.gov nor share it with anyone else.)

Tell us about yourself! I am... *

(Select an identity below)

An Individual

Yourself or another person whom
you represent with their consent

An Organization

A company, organization,
or government agency

Anonymous

A person who does not want their name
associated with the comment

Note: If you choose to identify as Anonymous, the option to enter your email address for submission confirmation is not available.

reCAPTCHA *

Solve with 2Captcha Do not submit personally identifiable information through this form. Any personally identifiable information (e.g., name, address, phone number) included in the comment form or in an attachment may be publicly disclosed in a docket or on the Internet (via Regulations.gov, a federal agency website, or a third-party, non-government website with access to publicly-disclosed data on Regulations.gov). By submitting a comment, you agree to the terms of participation and privacy notice.

Submit Comment

Please see the Privacy Notice and User Notice regarding comment submission.

Any information (e.g., personal or contact) you provide on this comment form or in an attachment may be publicly disclosed and searchable on the Internet and in a paper docket and will be provided to the Department or Agency issuing the notice. To view any additional information for submitting comments, such as anonymous or sensitive submissions, refer to the Privacy Notice and User Notice, the Federal Register notice on which you are commenting, and the Web site of the Department or Agency.

Classification

Agency
FDA
Published
June 2nd, 2026
Comment period closes
June 2nd, 2026 (60 days)
Instrument
Consultation
Legal weight
Non-binding
Stage
Consultation
Change scope
Minor
Docket
FDA-2026-N-2740-0001

Who this affects

Applies to
Healthcare providers Drug manufacturers Medical device makers
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Pharmaceuticals Medical Devices

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.